AGIO
Agios Pharmaceuticals, Inc.$39.88-0.11 (-0.28%)Prev Close$39.92·MCap$2.45B·P/E—·Vol446.7K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
27
$4.27M
◆
Net Activity
Net Seller
$4.27M
●
Active Insiders
8
last 12 mo
Over the past 12 months, insider activity at Agios Pharmaceuticals, Inc. (AGIO) has been exclusively selling, with 0 insider purchases totaling $0.00 and 27 insider sales totaling $4.27M. The most recent insider transaction was by Gheuens Sarah (officer: Chief Medical Officer), who sold $150.5K worth of shares on Jul 2, 2026. Agios Pharmaceuticals, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $2.45B.
AGIO Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | Gheuens Sarah | officer: Chief Medical Officer | Sell | 4,007 | $37.56 | $150.5K | 84,645 |
| Apr 6, 2026 | Burns James William | officer: Chief Legal Officer | Sell | 3,280 | $34.71 | $113.8K | 49,306 |
| Apr 6, 2026 | Gheuens Sarah | officer: Chief Medical Officer | Sell | 2,940 | $34.71 | $102.0K | 80,277 |
| Apr 6, 2026 | Goff Brian | director, officer: Chief Executive Officer | Sell | 19,068 | $34.71 | $661.9K | 184,508 |
| Apr 6, 2026 | Jones Cecilia | officer: Chief Financial Officer | Sell | 3,141 | $34.71 | $109.0K | 54,998 |
| Apr 6, 2026 | Milanova Tsveta | officer: Chief Commercial Officer | Sell | 3,262 | $34.71 | $113.2K | 46,829 |
| Apr 6, 2026 | Viswanadhan Krishnan | officer: Chief Corp Dev & Strategy | Sell | 2,959 | $34.71 | $102.7K | 10,282 |
| Mar 9, 2026 | Viswanadhan Krishnan | officer: Chief Corp Dev & Strategy | Sell | 2,959 | $27.80 | $82.3K | 5,141-37% |
| Mar 3, 2026 | Burns James William | officer: Chief Legal Officer | Sell | 4,031 | $28.96 | $116.7K | 44,086 |
| Mar 3, 2026 | Gheuens Sarah | officer: Chief Medical Officer | Sell | 2,868 | $28.96 | $83.1K | 71,593 |
| Mar 3, 2026 | Goff Brian | director, officer: Chief Executive Officer | Sell | 18,055 | $28.96 | $522.9K | 164,548 |
| Mar 3, 2026 | Jones Cecilia | officer: Chief Financial Officer | Sell | 5,035 | $28.96 | $145.8K | 49,328 |
| Mar 3, 2026 | Milanova Tsveta | officer: Chief Commercial Officer | Sell | 2,868 | $28.96 | $83.1K | 41,591 |
| Mar 3, 2026 | Washburn Theodore James Jr. | officer: Principal Accounting Officer | Sell | 2,223 | $28.96 | $64.4K | 6,140-27% |
| Jan 5, 2026 | Milanova Tsveta | Chief Commercial Officer | Sell | 2,872 | $27.02 | $77.6K | 0 |
| Dec 30, 2025 | Burns James William | Chief Legal Officer | Sell | 2,932 | $27.09 | $79.4K | 0 |
| Dec 30, 2025 | Goff Brian | Chief Executive Officer | Sell | 18,703 | $27.09 | $506.7K | 0 |
| Nov 12, 2025 | Scadden David | Director | Sell | 200 | $43.84 | $8.8K | 0 |
| Nov 11, 2025 | Gheuens Sarah | Chief Medical Officer | Sell | 2,454 | $43.78 | $107.4K | 0 |
| Oct 30, 2025 | Gheuens Sarah | Chief Medical Officer | Sell | 200 | $43.81 | $8.8K | 0 |
| Oct 27, 2025 | Gheuens Sarah | Chief Medical Officer | Sell | 3,302 | $43.92 | $145.0K | 0 |
| Oct 8, 2025 | Scadden David | Director | Sell | 200 | $41.00 | $8.2K | 0 |
| Sep 30, 2025 | Scadden David | Director | Sell | 200 | $40.00 | $8.0K | 0 |
| Sep 26, 2025 | Jones Cecilia | Chief Financial Officer | Sell | 3,651 | $36.77 | $134.2K | 0 |
| Sep 5, 2025 | Washburn Theodore James Jr. | Principal Accounting Officer | Sell | 8,546 | $36.87 | $315.1K | 0 |
| Aug 27, 2025 | Scadden David | Director | Sell | 200 | $40.00 | $8.0K | 0 |
| Aug 8, 2025 | Goff Brian | Chief Executive Officer | Sell | 11,085 | $36.67 | $406.5K | 0 |
| Jul 10, 2025 | Scadden David | Director | Sell | 1,400 | $40.00 | $56.0K | 0 |
| Jul 9, 2025 | Gheuens Sarah | Chief Medical Officer | Sell | 11,914 | $37.99 | $452.6K | 0 |
| Jul 1, 2025 | Gheuens Sarah | Chief Medical Officer | Sell | 4,091 | $34.17 | $139.8K | 0 |
| Jun 24, 2025 | Burns James William | Chief Legal Officer | Sell | 2,799 | $33.54 | $93.9K | 0 |
| Jun 24, 2025 | Gheuens Sarah | Chief Medical Officer | Sell | 2,909 | $33.54 | $97.6K | 0 |
| Jun 24, 2025 | Goff Brian | Chief Executive Officer | Sell | 18,700 | $33.54 | $627.2K | 0 |
| Jun 24, 2025 | Jones Cecilia | Chief Financial Officer | Sell | 1,780 | $33.54 | $59.7K | 0 |
| Jun 24, 2025 | Milanova Tsveta | Chief Commercial Officer | Sell | 2,770 | $33.54 | $92.9K | 0 |
| Apr 8, 2025 | FOUSE JACQUALYN A | Director | Sell | 7,497 | $25.90 | $194.2K | 0 |
| Mar 1, 2025 | Burns James William | Chief Legal Officer | Sell | 4,005 | $35.54 | $142.3K | 0 |
| Mar 1, 2025 | Goff Brian | Chief Executive Officer | Sell | 12,947 | $35.54 | $460.1K | 0 |
| Mar 1, 2025 | Jones Cecilia | Chief Financial Officer | Sell | 594 | $35.54 | $21.1K | 0 |
| Mar 1, 2025 | Washburn Theodore James Jr. | Principal Accounting Officer | Sell | 1,655 | $35.54 | $58.8K | 0 |
| Feb 1, 2025 | Washburn Theodore James Jr. | Principal Accounting Officer | Sell | 2,272 | $34.39 | $78.1K | 0 |
| Jan 3, 2025 | Milanova Tsveta | Chief Commercial Officer | Sell | 2,804 | $32.18 | $90.2K | 0 |
| Dec 11, 2024 | Scadden David | Director | Sell | 200 | $46.28 | $9.3K | 0 |
| Nov 8, 2024 | Washburn Theodore James Jr. | Principal Accounting Officer | Sell | 772 | $56.09 | $43.3K | 0 |
| Nov 7, 2024 | Ballal Rahul D. | Director | Sell | 20,000 | $55.86 | $1.12M | 0 |
| Nov 7, 2024 | Burns James William | Chief Legal Officer | Sell | 21,752 | $52.21 | $1.14M | 0 |
| Sep 26, 2024 | Jones Cecilia | Chief Financial Officer | Sell | 2,542 | $49.03 | $124.6K | 0 |
| Aug 8, 2024 | Goff Brian | Chief Executive Officer | Sell | 11,091 | $42.75 | $474.1K | 0 |
| Jul 1, 2024 | Gheuens Sarah | Chief Medical Officer | Sell | 3,705 | $43.85 | $162.5K | 0 |
| Jun 5, 2024 | Goff Brian | Chief Executive Officer | Sell | 12,115 | $48.84 | $591.7K | 0 |
Showing 1–50 of 143
1 / 3
AGIO Insider Buying Activity
The following table shows recent insider purchases of Agios Pharmaceuticals, Inc. (AGIO) stock reported via SEC Form 4 filings.
No insider buying activity found for AGIO in the last 12 months.
AGIO Insider Selling Activity
The following table shows recent insider sales of Agios Pharmaceuticals, Inc. (AGIO) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jul 2, 2026 | Gheuens Sarah | officer: Chief Medical Officer | Sell | 4,007 | $37.56 | $150.5K | 84,645 |
| Apr 6, 2026 | Burns James William | officer: Chief Legal Officer | Sell | 3,280 | $34.71 | $113.8K | 49,306 |
| Apr 6, 2026 | Gheuens Sarah | officer: Chief Medical Officer | Sell | 2,940 | $34.71 | $102.0K | 80,277 |
| Apr 6, 2026 | Goff Brian | director, officer: Chief Executive Officer | Sell | 19,068 | $34.71 | $661.9K | 184,508 |
| Apr 6, 2026 | Jones Cecilia | officer: Chief Financial Officer | Sell | 3,141 | $34.71 | $109.0K | 54,998 |
| Apr 6, 2026 | Milanova Tsveta | officer: Chief Commercial Officer | Sell | 3,262 | $34.71 | $113.2K | 46,829 |
| Apr 6, 2026 | Viswanadhan Krishnan | officer: Chief Corp Dev & Strategy | Sell | 2,959 | $34.71 | $102.7K | 10,282 |
| Mar 9, 2026 | Viswanadhan Krishnan | officer: Chief Corp Dev & Strategy | Sell | 2,959 | $27.80 | $82.3K | 5,141-37% |
| Mar 3, 2026 | Burns James William | officer: Chief Legal Officer | Sell | 4,031 | $28.96 | $116.7K | 44,086 |
| Mar 3, 2026 | Gheuens Sarah | officer: Chief Medical Officer | Sell | 2,868 | $28.96 | $83.1K | 71,593 |
| Mar 3, 2026 | Goff Brian | director, officer: Chief Executive Officer | Sell | 18,055 | $28.96 | $522.9K | 164,548 |
| Mar 3, 2026 | Jones Cecilia | officer: Chief Financial Officer | Sell | 5,035 | $28.96 | $145.8K | 49,328 |
| Mar 3, 2026 | Milanova Tsveta | officer: Chief Commercial Officer | Sell | 2,868 | $28.96 | $83.1K | 41,591 |
| Mar 3, 2026 | Washburn Theodore James Jr. | officer: Principal Accounting Officer | Sell | 2,223 | $28.96 | $64.4K | 6,140-27% |
| Jan 5, 2026 | Milanova Tsveta | Chief Commercial Officer | Sell | 2,872 | $27.02 | $77.6K | 0 |
| Dec 30, 2025 | Burns James William | Chief Legal Officer | Sell | 2,932 | $27.09 | $79.4K | 0 |
| Dec 30, 2025 | Goff Brian | Chief Executive Officer | Sell | 18,703 | $27.09 | $506.7K | 0 |
| Nov 12, 2025 | Scadden David | Director | Sell | 200 | $43.84 | $8.8K | 0 |
| Nov 11, 2025 | Gheuens Sarah | Chief Medical Officer | Sell | 2,454 | $43.78 | $107.4K | 0 |
| Oct 30, 2025 | Gheuens Sarah | Chief Medical Officer | Sell | 200 | $43.81 | $8.8K | 0 |
| Oct 27, 2025 | Gheuens Sarah | Chief Medical Officer | Sell | 3,302 | $43.92 | $145.0K | 0 |
| Oct 8, 2025 | Scadden David | Director | Sell | 200 | $41.00 | $8.2K | 0 |
| Sep 30, 2025 | Scadden David | Director | Sell | 200 | $40.00 | $8.0K | 0 |
| Sep 26, 2025 | Jones Cecilia | Chief Financial Officer | Sell | 3,651 | $36.77 | $134.2K | 0 |
| Sep 5, 2025 | Washburn Theodore James Jr. | Principal Accounting Officer | Sell | 8,546 | $36.87 | $315.1K | 0 |
| Aug 27, 2025 | Scadden David | Director | Sell | 200 | $40.00 | $8.0K | 0 |
| Aug 8, 2025 | Goff Brian | Chief Executive Officer | Sell | 11,085 | $36.67 | $406.5K | 0 |
| Jul 10, 2025 | Scadden David | Director | Sell | 1,400 | $40.00 | $56.0K | 0 |
| Jul 9, 2025 | Gheuens Sarah | Chief Medical Officer | Sell | 11,914 | $37.99 | $452.6K | 0 |
| Jul 1, 2025 | Gheuens Sarah | Chief Medical Officer | Sell | 4,091 | $34.17 | $139.8K | 0 |
| Jun 24, 2025 | Burns James William | Chief Legal Officer | Sell | 2,799 | $33.54 | $93.9K | 0 |
| Jun 24, 2025 | Gheuens Sarah | Chief Medical Officer | Sell | 2,909 | $33.54 | $97.6K | 0 |
| Jun 24, 2025 | Goff Brian | Chief Executive Officer | Sell | 18,700 | $33.54 | $627.2K | 0 |
| Jun 24, 2025 | Jones Cecilia | Chief Financial Officer | Sell | 1,780 | $33.54 | $59.7K | 0 |
| Jun 24, 2025 | Milanova Tsveta | Chief Commercial Officer | Sell | 2,770 | $33.54 | $92.9K | 0 |
| Apr 8, 2025 | FOUSE JACQUALYN A | Director | Sell | 7,497 | $25.90 | $194.2K | 0 |
| Mar 1, 2025 | Burns James William | Chief Legal Officer | Sell | 4,005 | $35.54 | $142.3K | 0 |
| Mar 1, 2025 | Goff Brian | Chief Executive Officer | Sell | 12,947 | $35.54 | $460.1K | 0 |
| Mar 1, 2025 | Jones Cecilia | Chief Financial Officer | Sell | 594 | $35.54 | $21.1K | 0 |
| Mar 1, 2025 | Washburn Theodore James Jr. | Principal Accounting Officer | Sell | 1,655 | $35.54 | $58.8K | 0 |
| Feb 1, 2025 | Washburn Theodore James Jr. | Principal Accounting Officer | Sell | 2,272 | $34.39 | $78.1K | 0 |
| Jan 3, 2025 | Milanova Tsveta | Chief Commercial Officer | Sell | 2,804 | $32.18 | $90.2K | 0 |
| Dec 11, 2024 | Scadden David | Director | Sell | 200 | $46.28 | $9.3K | 0 |
| Nov 8, 2024 | Washburn Theodore James Jr. | Principal Accounting Officer | Sell | 772 | $56.09 | $43.3K | 0 |
| Nov 7, 2024 | Ballal Rahul D. | Director | Sell | 20,000 | $55.86 | $1.12M | 0 |
| Nov 7, 2024 | Burns James William | Chief Legal Officer | Sell | 21,752 | $52.21 | $1.14M | 0 |
| Sep 26, 2024 | Jones Cecilia | Chief Financial Officer | Sell | 2,542 | $49.03 | $124.6K | 0 |
| Aug 8, 2024 | Goff Brian | Chief Executive Officer | Sell | 11,091 | $42.75 | $474.1K | 0 |
| Jul 1, 2024 | Gheuens Sarah | Chief Medical Officer | Sell | 3,705 | $43.85 | $162.5K | 0 |
| Jun 5, 2024 | Goff Brian | Chief Executive Officer | Sell | 12,115 | $48.84 | $591.7K | 0 |
AGIO Insiders
Similar Stocks to AGIO
VRTX
Vertex Pharmaceuticals Incorporated
$476.29+0.08%
$126.50B
REGN
Regeneron Pharmaceuticals, Inc.
$662.73+1.01%
$68.29B
ALNY
Alnylam Pharmaceuticals, Inc.
$275.93-1.72%
$43.19B
RVMD
Revolution Medicines, Inc.
$185.71+0.42%
$40.34B
MRNA
Moderna, Inc.
$68.11+1.00%
$27.09B
INSM
Insmed Incorporated
$109.25-0.67%
$25.06B
INCY
Incyte Corporation
$114.43-0.30%
$23.32B
UTHR
United Therapeutics Corporation
$530.63+0.75%
$23.22B